Stock Earnings

Question 1

Carisma Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Carisma Therapeutics Incの総資産は$30で、純lossは$-60です。

Question 2

CARMの主要な財務比率は何ですか？

Accepted Answer

Carisma Therapeutics Incの流動比率は0.51、純利益率は-315.78、1株当たり売上高は$0.45です。

Question 3

Carisma Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Carisma Therapeutics Inc largest revenue segment is Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy, at a revenue of 19,632,000 in the most earnings release.For geography, United States is the primary market for Carisma Therapeutics Inc, at a revenue of 19,632,000.

Question 4

Carisma Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Carisma Therapeutics Incの純lossは$-60です。

Question 5

Carisma Therapeutics Incに負債はありますか？

Accepted Answer

yes、Carisma Therapeutics Incの負債は58です。

Question 6

Carisma Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Carisma Therapeutics Incの総発行済株式数は41.75株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	10	19	14	40	26	11
Revenue Growth (YoY)	-50%	36%	-65%	54%	136%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	18	22	29	39	29	14
Research & Development	38	59	74	38	25	29
Operating Expenses	56	81	103	26	-2	32
Other Non Operating Income (Expenses)	1	--	--	0	0	0
Pretax Income	-49	-60	-86	-23	-8	-20
Income Tax Expense	0	--	--	-3	-8	1
Net Income	-49	-60	-86	-19	0	-22
Net Income Growth	-32%	-30%	353%	--	-100%	-79%
Shares Outstanding (Diluted)	41.78	41.45	33.52	10.03	9.12	5.91
Shares Change (YoY)	1%	24%	234%	10%	54%	30%
EPS (Diluted)	-1.18	-1.45	-2.59	-1.98	-0.04	-3.81
EPS Growth	-32%	-44%	31%	4,850%	-99%	-84%
Free Cash Flow	-37	-60	-82	24	-68	-30
Free Cash Flow Per Share	-0.88	-1.44	-2.44	2.39	-7.45	-5.07
Gross Margin	--	--	--	--	--	--
Operating Margin	-459.99%	-326.31%	-628.57%	32.5%	107.69%	-190.9%
Profit Margin	-490%	-315.78%	-614.28%	-47.5%	0%	-200%
Free Cash Flow Margin	-370%	-315.78%	-585.71%	60%	-261.53%	-272.72%
EBITDA	-44	-59	-86	13	28	-21
EBITDA Margin	-440%	-310.52%	-614.28%	32.5%	107.69%	-190.9%
D&A For EBITDA	2	3	2	0	0	0
EBIT	-46	-62	-88	13	28	-21
EBIT Margin	-459.99%	-326.31%	-628.57%	32.5%	107.69%	-190.9%
Effective Tax Rate	0%	--	--	13.04%	100%	-5%

Carisma Therapeutics Inc (CARM) Price

CARM Stock Price Chart

CARM Income

Follow-Up Questions